31 August 2021
D Smith
Via email: [FYI request #16312 email]
Dear D Smith
Request for information: Correspondence about Dexcom continuous glucose
monitors, Tandem t:slim X2 insulin pumps, and the Dexcom Inc acquisition
Thank you for your request dated 5 August 2021 under the Official Information Act 1982
(OIA) for information relating to correspondence between Pharmac and NZMS. You
requested:
All correspondence (including emails, phone records, meeting minutes and sent from
and to NZMS Diabetes or NZMS relating to the Dexcom G6, Dexcom G5, Tandem
Tslim X2 insulin pump or the acquisition by Dexcom Inc. received since January 14th
2021.
Please provide all information you hold directly relating to the upcoming meeting of
the Diabetes Subcommittee mentioned in this OIA release
https://pharmac.govt.nz/about/what-we-do/accountability-information/official-
information-act/2021-oia-responses/19-march-2021-oia-response-dexcom-
continuous-glucose-monitors-tandem-insulin-pump-documents-and-emails/
As required under the OIA, we wish to advise that we need to extend the time limit for
responding to your request. We have extended the time limit for your request by a further 20
working days, to
30 September 2021.
We have extended the time limit for your request as consultations necessary to make a
decision on the request is such that a proper response to the request cannot reasonably be
made within the original time limit (section 15A(1)(b) of the OIA).
Please note you have the right, by way of complaint under section 28(3) of the OIA to an
Ombudsman, to seek an investigation and review of our decision.
Please get in touch with us if you have any questions about this.
Yours sincerely
Rachel Read
Manager, Policy and Government Services
2021-22-016; A1517590
Document Outline
